ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 24.39 Data as of Dec 06 |  -0.09 / -0.37%Today’s Change | 4.17 Today|||52-Week Range 29.73 | +424.52% Year-to-Date |
Latest ACAD News | Press Releases
| ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Winner Dec 04 / TheStreet.com | ACADIA Pharmaceuticals (ACAD) Highlighted As Today's Perilous Reversal Stock Dec 03 / TheStreet.com |
Today’s Trading
| Previous close | 24.48 |
| Today’s open | 24.79 |
| Day’s range | -- - -- |
| Volume | 641,402 |
| Average volume (3 months) | 2,579,252 |
| Market cap | $2.2B |
| Dividend yield | -- |
Data as of 12/06/2013
Growth & Valuation
| Earnings growth (last year) | +13.64% |
| Earnings growth (this year) | -16.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +137.40% |
| P/E ratio | NM |
| Price/Sales | 52.23 |
| Price/Book | 21.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MDCOThe Medicines Co | -0.71 | -1.82% |
| WXWuXi Pharmatech (Cay... | -0.14 | -0.43% |
| SNTSSantarus Inc | -0.02 | -0.06% |
| AKRXAkorn Inc | +0.15 | +0.59% |
Data as of 12/06/2013
Financials
| Next reporting date | March 4, 2014 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $4.9M |
| Annual profit (last year) | -$20.8M |
| Net profit margin | -424.88% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Uli Hacksell |
Treasurer, Chief Financial & Business Officer Thomas H. Aasen |
Corporate headquarters San Diego, California |
Forecasts
